« Back
Home /
Abiraterone N-Oxide

Abiraterone N-Oxide

Item no.	TRC-A108540-2,5mg
Manufacturer	Toronto Research Chemicals
Amount	2,5mg
Category	Oncology
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Mol. Formula	C24H31NO2
Mol. Weight	365, 51
Appearance	White Solid
Application Notes	Abiraterone N-Oxide is a derivative of Abiraterone (A108490), a steroidal cytochrome P 450 17alpha-hydroxylase-17, 20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
Melting Pt.	>240C (dec.)
Boiling Pt.	No Data Available
Solubility	Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Stability	No Data Available
Storage Condition	Hygroscopic, Refrigerator, under inert atmosphere

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

TRC-A108540-2,5mg-safety-datasheet.pdf